Chondrocyte Viability at Time of Transplantation for Osteochondral Allografts Preserved by the Missouri Osteochondral Preservation System versus Standard Tissue Bank Protocol

Aaron M. Stoker; James P. Stannard; James L. Cook

doi:10.1055/s-0037-1608947

The Journal of Knee Surgery, Table of Contents

J Knee Surg 2018; 31(08): 772-780
DOI: 10.1055/s-0037-1608947

Original Article

Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Chondrocyte Viability at Time of Transplantation for Osteochondral Allografts Preserved by the Missouri Osteochondral Preservation System versus Standard Tissue Bank Protocol

Authors

Aaron M. Stoker

¹Department of Orthopaedic Surgery, University of Missouri, Columbia, Missouri

²Thompson Laboratory for Regenerative Orthopaedics, University of Missouri, Columbia, Missouri
James P. Stannard

¹Department of Orthopaedic Surgery, University of Missouri, Columbia, Missouri

²Thompson Laboratory for Regenerative Orthopaedics, University of Missouri, Columbia, Missouri
James L. Cook

¹Department of Orthopaedic Surgery, University of Missouri, Columbia, Missouri

²Thompson Laboratory for Regenerative Orthopaedics, University of Missouri, Columbia, Missouri

Abstract

The Missouri Osteochondral Preservation System (MOPS) has been reported to effectively preserve osteochondral allografts (OCAs) twice as long as current tissue bank protocols in preclinical studies. However, viability of OCAs preserved using the MOPS protocol at the time of clinical implantation compared with the current standard of care (SOC) is not known. Viable chondrocyte density (VCD) at time of transplantation will be significantly higher in OCAs preserved using the MOPS protocol compared with OCAs preserved using the current tissue bank protocol and will significantly affect clinical complication rates. Femoral condyle OCAs were obtained from American Association of Tissue Banks accredited tissue banks for clinical use. The OCAs were stored using the current SOC protocol for each respective tissue bank (n = 26) or the MOPS protocol (n = 50). Nonimplanted femoral condyle OCA tissue normally discarded after surgery was collected and assessed for VCD within 1 hour after surgery. Control OCA samples (n = 34) were obtained from one tissue bank. VCD was determined using a validated cell viability assay. Patients (n = 76) had in-clinic follow-up at least 6 months after OCA transplantation. At the time of clinical implantation, mean storage time for OCAs in the SOC cohort was 20.4 days, and in the MOPS cohort was 44.2 days, after procurement. VCD in OCAs in the MOPS cohort was not significantly different from normal healthy cartilage VCD and 100% were above the desired minimum essential level 70% of control VCD at the time of transplantation. VCD in OCAs in the SOC cohort was significantly (p < 0.001) lower than controls and MOPS, and only 27% were above 70% of control VCD at the time of transplantation. MOPS preserves OCA chondrocyte viability at significantly higher levels than current tissue bank storage protocols for a longer period of time after procurement. All MOPS-preserved OCAs exceeded minimum essential VCD levels for up to 56 days after procurement.

Keywords

osteoarthritis - osteochondral allografts - preservation systems - chondrocyte viability - cartilage

Full Text

References

References
1 Elders MJ. The increasing impact of arthritis on public health. J Rheumatol Suppl 2000; 60: 6-8
2 Wainwright C, Theis J-C, Garneti N, Melloh M. Age at hip or knee joint replacement surgery predicts likelihood of revision surgery. J Bone Joint Surg Br 2011; 93 (10) 1411-1415
3 Carr AJ, Robertsson O, Graves S. , et al. Knee replacement. Lancet 2012; 379 (9823): 1331-1340
4 Ritter MA, Lutgring JD, Davis KE, Faris PM, Berend ME. Total knee arthroplasty effectiveness in patients 55 years old and younger: osteoarthritis vs. rheumatoid arthritis. Knee 2007; 14 (01) 9-11
5 Rand JA, Trousdale RT, Ilstrup DM, Harmsen WS. Factors affecting the durability of primary total knee prostheses. J Bone Joint Surg Am 2003; 85-A (02) 259-265
6 Meehan JP, Danielsen B, Kim SH, Jamali AA, White RH. Younger age is associated with a higher risk of early periprosthetic joint infection and aseptic mechanical failure after total knee arthroplasty. J Bone Joint Surg Am 2014; 96 (07) 529-535
7 Jackson JD, Smith J, Shah JP, Wisniewski SJ, Dahm DL. Golf after total knee arthroplasty: do patients return to walking the course?. Am J Sports Med 2009; 37 (11) 2201-2204
8 Wylde V, Blom A, Dieppe P, Hewlett S, Learmonth I. Return to sport after joint replacement. J Bone Joint Surg Br 2008; 90 (07) 920-923
9 Sakellariou VI, Poultsides LA, Ma Y, Bae J, Liu S, Sculco TP. Risk assessment for chronic pain and patient satisfaction after total knee arthroplasty. Orthopedics 2016; 39 (01) 55-62
10 Bayliss LE, Culliford D, Monk AP. , et al. The effect of patient age at intervention on risk of implant revision after total replacement of the hip or knee: a population-based cohort study. Lancet 2017; 389 (10077): 1424-1430
11 Liddle AD, Judge A, Pandit H, Murray DW. Adverse outcomes after total and unicompartmental knee replacement in 101,330 matched patients: a study of data from the National Joint Registry for England and Wales. Lancet 2014; 384 (9952): 1437-1445
12 Mithoefer K, McAdams T, Williams RJ, Kreuz PC, Mandelbaum BR. Clinical efficacy of the microfracture technique for articular cartilage repair in the knee: an evidence-based systematic analysis. Am J Sports Med 2009; 37 (10) 2053-2063
13 Gross AE, Silverstein EA, Falk J, Falk R, Langer F. The allotransplantation of partial joints in the treatment of osteoarthritis of the knee. Clin Orthop Relat Res 1975; (108) 7-14
14 Milano G, Sanna Passino E, Deriu L. , et al. The effect of platelet rich plasma combined with microfractures on the treatment of chondral defects: an experimental study in a sheep model. Osteoarthritis Cartilage 2010; 18 (07) 971-980
15 Erggelet C, Endres M, Neumann K. , et al. Formation of cartilage repair tissue in articular cartilage defects pretreated with microfracture and covered with cell-free polymer-based implants. J Orthop Res 2009; 27 (10) 1353-1360
16 Siclari A, Mascaro G, Gentili C, Cancedda R, Boux E. A cell-free scaffold-based cartilage repair provides improved function hyaline-like repair at one year. Clin Orthop Relat Res 2012; 470 (03) 910-919
17 Harris JD, Siston RA, Pan X, Flanigan DC. Autologous chondrocyte implantation: a systematic review. J Bone Joint Surg Am 2010; 92 (12) 2220-2233
18 Knutsen G, Engebretsen L, Ludvigsen TC. , et al. Autologous chondrocyte implantation compared with microfracture in the knee. A randomized trial. J Bone Joint Surg Am 2004; 86-A (03) 455-464
19 Smyth NA, Ross KA, Haleem AM. , et al. Platelet-rich plasma and hyaluronic acid are not synergistic when used as biological adjuncts with autologous osteochondral transplantation. Cartilage 2018; 9 (03) 321-328
20 Sherman SL, Garrity J, Bauer K, Cook J, Stannard J, Bugbee W. Fresh osteochondral allograft transplantation for the knee: current concepts. J Am Acad Orthop Surg 2014; 22 (02) 121-133
21 Nuelle CW, Nuelle JA, Cook JL, Stannard JP. Patient factors, donor age, and graft storage duration affect osteochondral allograft outcomes in knees with or without comorbidities. J Knee Surg 2017; 30 (02) 179-184
22 Gross AE, Kim W, Las Heras F, Backstein D, Safir O, Pritzker KP. Fresh osteochondral allografts for posttraumatic knee defects: long-term followup. Clin Orthop Relat Res 2008; 466 (08) 1863-1870
23 Gracitelli GC, Tirico LEP, McCauley JC, Pulido PA, Bugbee WD. Fresh osteochondral allograft transplantation for fractures of the knee. Cartilage 2017; 8 (02) 155-161
24 Nielsen ES, McCauley JC, Pulido PA, Bugbee WD. Return to sport and recreational activity following osteochondral allograft transplantation in the knee. Am J Sports Med 2017; 45 (07) 1608-1614
25 Frank RM, Lee S, Levy D. , et al. Osteochondral allograft transplantation of the knee: analysis of failures at 5 years. Am J Sports Med 2017; 45 (04) 864-874
26 Assenmacher AT, Pareek A, Reardon PJ, Macalena JA, Stuart MJ, Krych AJ. Long-term outcomes after osteochondral allograft: a systematic review at long-term follow-up of 12.3 years. Arthroscopy 2016; 32 (10) 2160-2168
27 Gross AE, Shasha N, Aubin P. Long-term followup of the use of fresh osteochondral allografts for posttraumatic knee defects. Clin Orthop Relat Res 2005; (435) 79-87
28 Cook JL, Hung CT, Lima E, Stoker A. Tissue preservation system. U.S. Patent: 9,220,258 (Issued Dec. 29, 2015). Available at: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=9,220,258.PN.&OS=PN/9,220,258&RS=PN/9,220,258 . Accessed September 25, 2017
29 Cook JL, Stannard JP, Stoker AM. , et al. Importance of donor chondrocyte viability for osteochondral allografts. Am J Sports Med 2016; 44 (05) 1260-1268
30 Farr J, Gracitelli GC, Shah N, Chang EY, Gomoll AH. High Failure rate of a decellularized osteochondral allograft for the treatment of cartilage lesions. Am J Sports Med 2016; 44 (08) 2015-2022
31 Pallante AL, Chen AC, Ball ST. , et al. The in vivo performance of osteochondral allografts in the goat is diminished with extended storage and decreased cartilage cellularity. Am J Sports Med 2012; 40 (08) 1814-1823
32 Stoker A, Garrity JT, Hung CT, Stannard JP, Cook J. Improved preservation of fresh osteochondral allografts for clinical use. J Knee Surg 2012; 25 (02) 117-125
33 Garrity JT, Stoker AM, Sims HJ, Cook JL. Improved osteochondral allograft preservation using serum-free media at body temperature. Am J Sports Med 2012; 40 (11) 2542-2548
34 Bugbee WD, Pallante-Kichura AL, Görtz S, Amiel D, Sah R. Osteochondral allograft transplantation in cartilage repair: graft storage paradigm, translational models, and clinical applications. J Orthop Res 2016; 34 (01) 31-38
35 Williams SK, Amiel D, Ball ST. , et al. Prolonged storage effects on the articular cartilage of fresh human osteochondral allografts. J Bone Joint Surg Am 2003; 85-A (11) 2111-2120
36 Pallante AL, Bae WC, Chen AC, Görtz S, Bugbee WD, Sah RL. Chondrocyte viability is higher after prolonged storage at 37 degrees C than at 4 degrees C for osteochondral grafts. Am J Sports Med 2009; 37 (Suppl. 01) 24S-32S
37 Malinin T, Temple HT, Buck BE. Transplantation of osteochondral allografts after cold storage. J Bone Joint Surg Am 2006; 88 (04) 762-770
38 Cook JL, Stoker AM, Stannard JP. , et al. A novel system improves preservation of osteochondral allografts. Clin Orthop Relat Res 2014; 472 (11) 3404-3414
39 Stoker AM, Stannard JP, Kuroki K, Bozynski CC, Pfeiffer FM, Cook JL. Validation of the Missouri Osteochondral Preservation System for Maintenance of Osteochondral Allograft Quality During Prolonged Storage. Am J Sports Med 2018; 46 (01) 58-65
40 Waters NP, Stoker AM, Pfeiffer FM, Cook JL. Biomarkers affected by impact severity during osteochondral injury. J Knee Surg 2015; 28 (03) 191-200
41 Lewis JL, Deloria LB, Oyen-Tiesma M, Thompson Jr RC, Ericson M, Oegema Jr TR. Cell death after cartilage impact occurs around matrix cracks. J Orthop Res 2003; 21 (05) 881-887
42 Allen RT, Robertson CM, Pennock AT. , et al. Analysis of stored osteochondral allografts at the time of surgical implantation. Am J Sports Med 2005; 33 (10) 1479-1484
43 Pearsall IV AW, Tucker JA, Hester RB, Heitman RJ. Chondrocyte viability in refrigerated osteochondral allografts used for transplantation within the knee. Am J Sports Med 2004; 32 (01) 125-131
44 Williams III RJ, Dreese JC, Chen CT. Chondrocyte survival and material properties of hypothermically stored cartilage: an evaluation of tissue used for osteochondral allograft transplantation. Am J Sports Med 2004; 32 (01) 132-139
45 Csönge L, Bravo D, Newman-Gage H. , et al. Banking of osteochondral allografts, Part II. Preservation of chondrocyte viability during long-term storage. Cell Tissue Bank 2002; 3 (03) 161-168
46 Kwan MK, Wayne JS, Woo SL, Field FP, Hoover J, Meyers M. Histological and biomechanical assessment of articular cartilage from stored osteochondral shell allografts. J Orthop Res 1989; 7 (05) 637-644
47 Amiel D, Harwood FL, Hoover JA, Meyers M. A histological and biochemical assessment of the cartilage matrix obtained from in vitro storage of osteochondral allografts. Connect Tissue Res 1989; 23 (01) 89-99